News

Robles BioCeutics Files Paradigm Shifting Paten...

Regenerative Dermatology Company Successfully Applies "Injury Mimetic" Stimulated Stem Cell Grafts to Treatment of Third Largest Cause of Death in USA SAN DIEGO, Dec. 31, 2024 /PRNewswire/ -- Robles BioCeutics announced new data...

Robles BioCeutics CEO Maria Robles Named Finali...

Founder of First Senolytic Based Regenerative Dermatology Company to Honored for Contributions SAN DIEGO, Dec. 12, 2024 /PRNewswire/ -- Robles BioCeutics announced today that its CEO, Maria Robles, has been selected as a...

Robles BioCeutics Appoints Renowned Stem Cell D...

Leading Regenerative Dermatology Company Gears Up for Accelerated Clinical Translation of Stem Cell-Based Dermatology Pipeline SAN DIEGO, Dec. 4, 2024 /PRNewswire/ -- Robles BioCeutics, a science-driven regenerative dermatology company, announced today the appointment...

Robles BioCeutics LLC Collaborates with BioCent...

SAN DIEGO, Nov. 8, 2024 /PRNewswire/ -- Robles BioCeutics LLC, a regenerative dermatology company, is pleased to announce a new collaboration with BioCentrium aimed at advancing research into the molecular mechanisms behind...

Robles BioCeutics Files Landmark Patent on Firs...

Regenerative Dermatology Company Succeeds in Increasing Exosome Quantity and Quality by Toll Like Receptor Manipulation SAN DIEGO, Sept. 27, 2024 /PRNewswire/ -- Robles BioCeutics, a regenerative dermatology company, announced today the submission...